Powder Pharms patents expiration

1. Zingo patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8540665 POWDER PHARMS Particle cassettes and processes therefor
Oct, 2029

(6 years from now)

US9358338 POWDER PHARMS Particle cassettes and processes therefor
Apr, 2035

(11 years from now)

US9370622 POWDER PHARMS Devices and methods for delivering particles
Sep, 2035

(12 years from now)

Drugs and Companies using LIDOCAINE HYDROCHLORIDE ingredient

Market Authorisation Date: 16 August, 2007

Treatment: Zingo intradermal injection system is a drug delivery system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action; Zingo is a powder intrader...


More Information on Dosage

ZINGO family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic